Orthofix Medical (OFIX) Stock Price
Orthofix Medical Price
Revenue has compounded at 4.4% per year over the past 19 years to 822.31 M USD. Earnings per share have declined at 11.6% per year over the last 13 years. Orthofix Medical's net margin stands at -11.2%, down from -8.3% several years earlier. Analysts set a median price target of 13.00 USD, implying 32.5% above the current price. Of 11 analysts, 8 rate the stock a buy — an overall Buy consensus.
Orthofix Medical stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Orthofix Medical business model & stock analysis
Frequently asked questions about Orthofix Medical
The business model of Orthofix Medical Inc. revolves around providing innovative medical solutions for the orthopedic and spine markets. The company focuses on developing, manufacturing, and marketing advanced medical devices and non-invasive orthopedic solutions. Orthofix Medical Inc. aims to improve patients' quality of life by offering technologically advanced products and therapies that aid in the treatment of various musculoskeletal conditions. They strive to deliver exceptional patient outcomes by combining industry-leading technology, clinical expertise, and evidence-based medicine. Orthofix Medical Inc. is committed to driving innovation, advancing patient care, and solidifying its position as a leading player in the orthopedic medical device industry.
Orthofix Medical Inc is primarily active in the healthcare industry, specifically focusing on orthopedic medical devices. With a strong commitment to improving patient mobility and quality of life, Orthofix offers a wide range of innovative products and solutions in spine fixation, bone growth stimulation, and biologics. Their expertise in orthopedics allows them to serve various healthcare professionals, including surgeons, physicians, and hospitals worldwide. Orthofix Medical Inc's extensive experience and dedication to advancing orthopedic care make them a key player in the industry, providing valuable solutions for patients and healthcare providers alike.
The main competitors of Orthofix Medical Inc in the market include Stryker Corporation, Zimmer Biomet Holdings Inc, DJO Global, Inc, and Medtronic PLC.
Orthofix Medical Inc. is a renowned medical device company with a rich history and background. Established in 1987, Orthofix has been dedicated to advancing orthopedic solutions and improving patient outcomes. With its headquarters in Lewisville, Texas, the company operates through various business segments, including Spinal Implants, Biologics, and External Fixation. Orthofix is committed to delivering innovative and high-quality products that help patients regain mobility and improve their quality of life. The company has a global presence and serves healthcare providers and patients worldwide. With its strong focus on research and development, Orthofix continues to shape the future of orthopedic care.
Orthofix Medical Inc has achieved significant milestones throughout its history. One notable achievement is the company's development of innovative medical devices and solutions for orthopedic and spine conditions. Additionally, Orthofix Medical Inc has successfully expanded its global presence, reaching healthcare professionals and patients worldwide. The company has also demonstrated its commitment to research and development, continuously introducing advanced technologies and treatments in the orthopedic field. Moreover, Orthofix Medical Inc has made strategic acquisitions and partnerships, further enhancing its product portfolio and market position. These milestones showcase Orthofix Medical Inc's dedication to improving patient outcomes and advancing the field of orthopedics.
Orthofix Medical Inc is primarily present in countries and regions worldwide. The company operates in North America, Europe, Asia-Pacific, Latin America, and the Middle East. With a global presence, Orthofix Medical Inc has established a strong market position and serves patients and healthcare professionals in multiple countries and regions.
Orthofix Medical Inc represents the values of innovation, integrity, and patient-centricity. With a corporate philosophy deeply rooted in improving patients' lives, Orthofix Medical Inc is committed to developing and providing innovative orthopedic solutions. The company strives to maintain the highest standards of integrity and ethical conduct in all its operations. Through its cutting-edge technologies and dedication to research and development, Orthofix Medical Inc aims to deliver advanced medical devices and therapies that meet the unique needs of patients worldwide.
Analysts currently set an average price target of 13.40 USD for the Orthofix Medical stock (median: 13.00 USD), implying +36.6 % versus the latest price. The consensus is based on 11 analyst ratings.
11 analysts currently rate the Orthofix Medical stock: 8 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Orthofix Medical to generate revenue of 851.20 M USD and earnings per share of -1.16 USD.
Converted at the current exchange rate, the Orthofix Medical share trades at 8.73 EUR (9.81 USD).
The Orthofix Medical share (OFIX) is listed on 2 stock exchanges, including: NASDAQ (OFIX), Frankfurt (OM2.F).
Orthofix Medical Inc is a globally leading medical technology company specializing in innovative orthopedic products in the global market. The company is headquartered in Lewisville, Texas, and has offices in over 50 countries. Orthofix Medical Inc specializes in providing high-quality solutions for complex orthopedic problems. Orthofix Medical consists of four main business areas: Extremities, Spine, Biologics, and International Operations. The Extremities division focuses on manufacturing products and instruments that target wrist and elbow surgery. The Spine division produces solutions for a variety of back problems, including herniated discs, scoliosis, and other complications. Biologics produces biological products that promote natural body regeneration and are suitable for use in orthopedic surgery. The International division supports the businesses that Orthofix Medical Inc operates in Europe, Asia, Latin America, and other regions of the world. Orthofix Medical Inc offers a wide range of products, including orthopedic implants, surgical instruments, bio-implants, and biological allografts. The company is a leader in developing solutions for bone regeneration and arthroscopic surgery. Among Orthofix Medical Inc's most well-known products are the M6-C core replacement, Octopus leg holder, and Trinity-ELITE bone replacement. In addition to its core competency of manufacturing high-quality orthopedic products, Orthofix Medical also offers innovative services. Orthofix Medical Inc provides its customers with training, certification programs, technical support, and consultation. Supporting physicians and clinics is an important part of Orthofix Medical's business philosophy. The business strategy of Orthofix Medical Inc aims to promote company growth through organic expansion and strategic acquisitions of companies operating in the fields of orthopedics, biology, and surgery. The company continuously invests in research and development to develop innovative solutions to address complex orthopedic challenges. Orthofix Medical Inc is also committed to high social and environmentally-friendly standards. The company follows a proactive environmental policy and strives to utilize resources efficiently and reduce waste. Orthofix Medical's corporate responsibility is also evident in its support of nonprofit organizations and its employees' involvement in supporting social projects. Overall, Orthofix Medical Inc has taken a leading role in the orthopedic industry by offering innovative products and services that help clinics and physicians address complex orthopedic problems. The company is committed to promoting its growth through continuous innovation and a proactive commitment to social and environmental responsibility.
The expected revenue of Orthofix Medical is 851.20 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Orthofix Medical is -46.53 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Orthofix Medical is currently -8.43. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Orthofix Medical stock.
The price-to-sales ratio (P/S) of Orthofix Medical is currently 0.46. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Orthofix Medical stock.
The Eulerpool Quality Score for Orthofix Medical is 3/10.
The ISIN of Orthofix Medical is US68752M1080. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Orthofix Medical is A2NB0X. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Orthofix Medical is OFIX. The ticker symbol is used to trade Orthofix Medical shares on the stock exchange.
Orthofix Medical stock
Orthofix Medical Peer Group
Orthofix Medical Ticker
Orthofix Medical FIGI
All fundamentals and in-depth analysis of Orthofix Medical
Our stock analysis for Orthofix Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orthofix Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.